Stock vs Stock Comparison

The Cigna Group vs Agilent Technologies, Inc.

A wins the Tale of the Tape 5–3.

CI$270.73
A$137.40

🏆 Tale of the Tape

35
CIA
2.2%Profitability (Net Margin)18.8%
2.4xValuation (P/E)27.3x
4.6%Efficiency (ROIC)11.8%
5/9Health (Piotroski F)5/9
2.7Safety (Altman Z)4.6
12.5%Growth (Rev YoY)6.7%
-0.38Risk (Sharpe 1Y)0.32
2.77xBalance Sheet (D/E)0.89x
8.77%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.113
252-Day Correlation
0.107
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCIA
Market Cap$73.4B$38.2B
P/E Ratio2.4x27.3x
Forward P/E8.3x20.5x
P/B1.74x5.37x
Dividend Yield2.25%0.75%
Beta0.311.22

Quantitative Metrics

MetricCIA
DCF Fair Value$608.57$50.34
DCF Upside+121.2%-57.1%
Piotroski F5/95/9
Altman Z2.734.57
Beneish M-2.46
FCF Yield8.77%3.41%
Net Debt/EBITDA1.9x0.7x
ROIC4.6%11.8%
WACC6.8%12.1%
ROIC – WACC-2.2pp-0.3pp
Gross Margin52.4%
Net Margin2.2%18.8%
Rev Growth YoY12.5%6.7%
Sharpe (1Y)-0.380.32
Max Drawdown 3Y
FCF Payout Ratio19%24%

CI Price

Loading chart...

A Price

Loading chart...

ETF Exposure

CI found in:

XHS1.94%
XLV1.39%
VHT1.26%
VFVA0.89%
ONEV0.78%
ONEO0.43%
MGV0.38%
VYM0.32%
VTV0.30%
SCHV0.26%
SPYV0.26%
QUS0.24%
VONV0.22%
IWD0.21%
RSP0.20%
ESGV0.14%
SPLG0.14%
IVV0.13%
SCHX0.12%
VONE0.12%
VOO0.12%
SCHB0.12%
SPY0.12%
ITOT0.11%
VTI0.11%
SPTM0.11%
URTH0.09%
ACWI0.07%
VT0.07%
IWF0.02%
VONG0.02%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

CI vs A: Head-to-Head Analysis

The Cigna Group (CI) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 5–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, CI generates a return on invested capital (ROIC) of 4.6% compared to A's 11.8%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between CI and A is 0.113, indicating low correlation, making them an effective diversification pair in a portfolio context.

CI appears in 31 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, CI or A?

Our quantitative analysis compares CI and A across nine fundamental dimensions. A wins the Tale of the Tape 5–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are CI and A correlated?

The 252-day correlation between CI and A is 0.113. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.